Skip to content

Effectiveness of Electromagnetic Field Therapy in Chronic Constipation

Effects of Transabdominal Magnetic Field Therapy on Constipation Severity in Chronic Functional Constipation: A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06578442
Enrollment
75
Registered
2024-08-29
Start date
2019-02-01
Completion date
2026-04-28
Last updated
2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation, Electrotherapy

Keywords

Quality of Life, Magnetic Fields

Brief summary

This study was a prospective randomise controlled study. The aim of this study was to determine the effect of transabdominal magnetic field therapy on constipation severity in patients with chronic functional constipation. After eligibility assessment and baseline measurements, participants were randomly allocated into three groups: the transabdominal magnetic field therapy group, the sham group, and the standard care group. All groups received Constipation Management Education. The education program, developed based on the literature, covered the definition, causes, risk factors, medication use, and lifestyle-related factors associated with constipation. In addition, behavioral recommendations were provided, including maintaining regular bowel habits, adopting an appropriate defecation posture, avoiding delayed defecation and excessive straining, and optimizing diet, fluid intake, and physical activity. The MFT group received active transabdominal magnetic field therapy twice weekly for 8 weeks. The sham group underwent the same device placement and session protocol; however, the device was used without delivering an active magnetic field. The standard care group received only Constipation Management Education. Participants were followed face to face for 8 weeks, and individual counseling was provided when needed to answer their questions. The primary outcome measure was the Constipation Severity Instrument (CSI). Secondary outcomes were the CSI subscales, the Patient Assessment of Constipation Quality of Life questionnaire (PAC-QOL), the Bristol Stool Form Scale, complete spontaneous bowel movements (CSBM), and defecation time.

Interventions

Magnetic Field Treatment was applied to the participants for 30 minutes a day, twice a week for 8 weeks, using an electromagnetic field therapy device, in a supine position, by placing circular magnetotherapy electrodes in the abdominal area, at 25 Hz and 30 Gauss power.

The standard care group received "training on how to manage constipation".

OTHERSham (No Treatment)

The sham group underwent the same procedure without active stimulation.

Sponsors

Medipol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This was a three-arm, parallel-group interventional study. Participants were randomly assigned to active transabdominal magnetic field therapy, sham intervention, or standard care.

Eligibility

Sex/Gender
ALL
Age
18 Years to 68 Years
Healthy volunteers
Yes

Inclusion criteria

* Presence of chronic constipation according to Rome III criteria * Ages of 18-68 * Indicate magnetotherapy treatment, * Not having used any medication for constipation during the treatment * Fully cooperative

Exclusion criteria

* Severely obese patients * Electrical implants in their body * First trimester of pregnancy * Implanted inner ear implants * Small implants that may be affected by the magnetic field * Epilepsy * Untreated hypertoid * High fever

Design outcomes

Primary

MeasureTime frameDescription
Constipation Severity Instrument (CSI)Eight weeksIt is a scale that reveals the symptoms of constipation in people. It makes an evaluation to determine the problems experienced by individuals in defecation. The scale includes 16 questions. The lowest total score that can be obtained from the scale is 0 and the highest is 73. A high score indicates that the symptoms are serious.

Secondary

MeasureTime frameDescription
Patient Assessment of Constipation Quality of Life (PAC-QOL)Eight weeksQuality of life was assessed using the Turkish adaptation of the Patient Assessment of Constipation Quality of Life(PAC-QOL). The PAC-QOL consists of 28 questions, including subscales for "physical discomfort," "psychosocial discomfort," "concerns/worries," and "satisfaction." The highest possible score is 140, and the lowest is 28. Higher scores indicate that constipation negatively impacts quality of life more significantly.
Bristol Stool ScaleEight weeksThis is a scale that evaluates stool consistency. A high score indicates a more liquid stool consistency. Type 3-4 indicates normal stool.
Complete spontaneous bowel movements (CSBM)Eight weeksThis is a medical term referring to bowel movements that occur naturally without medication, and without straining, pain, or a feeling of incomplete emptying during defecation.
Defecation timeEight weeksIt describes the frequency of bowel movements, the consistency of the stool, and the degree of difficulty a person experiences during defecation. It is recorded in minutes. A longer duration indicates difficulty in defecation.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATOREsra Atilgan, PhD

Medipol University

PRINCIPAL_INVESTIGATORGizem Boztas Elverisli, PhD

Medipol University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 9, 2026